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Abstract
 
Mucosal immunoglobulin (Ig)A dominance has been proposed to be associated with preferen-
tial class switch recombination (CSR) to the IgA heavy chain constant region, 
 
C
 
 
 
. Here, we
report that B cell activation in nasal-associated lymphoid tissue (NALT) upon stimulation with
the hapten (4-hydroxy-3-nitrophenyl)acetyl (NP) coupled to chicken 
 
 
 
 globulin caused an
anti-NP memory response dominated by high affinity IgA antibodies. In the response, how-
ever, NP-specific IgG
 
 
 
 B cells expanded and sustained their number as a major population in
germinal centers (GCs), supporting the view that CSR to IgG heavy chain constant region,
 
C
 
 
 
, operated efficiently in NALT. Both IgG
 
 
 
 and IgA
 
 
 
 GC B cells accumulated somatic mu-
tations, indicative of affinity maturation to a similar extent, suggesting that both types of cell
were equally selected by antigen. Despite the selection in GCs, high affinity NP-specific B cells
were barely detected in the IgG memory compartment, whereas such cells dominated the IgA
memory compartment. Taken together with the analysis of the V
 
H
 
 gene clonotype in GC and
memory B cells, we propose that NALT is equipped with a unique machinery providing IgA-
specific enrichment of high affinity cells into the memory compartment, facilitating immunity
with high affinity and noninflammatory secretory antibodies.
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Introduction
 
Mucosal surfaces are exposed to pathogenic organisms and
foreign antigens, and are thus major sites for the start of in-
fection and inflammation. M cells in the follicular epithelial
 
layer of the mucosa-associated lymphoid tissues (MALTs)
 
*
 
transcytose the pathogenic organisms and foreign antigens
to underlying APCs (for reviews, see references 1–3).
APCs process antigens and stimulate antigen-specific CD4
 
 
 
Th cells in MALT, which, in turn, results in activation of B
cells (1–3). The mucosal B cell response is dominated by
IgA antibody production, a feature strikingly different from
that in peripheral lymphoid organs (1–3). Consequently,
mucosal surfaces are covered with secretions containing
large amounts of secretory IgA that plays a critical role in
facilitating defense against exposure to numerous environ-
mental antigens (4). Mucosal IgA dominance is considered
to reflect a preferential class switch recombination (CSR)
from 
 
 
 
 to 
 
 
 
 (5), through stimulation with TGF-
 
 
 
, IL-10,
and CD40 (6–9); however, the mechanism of this process
in vivo is not fully understood.
Analysis of the nonmucosal immune system indicates
that, in response to T cell–dependent antigens, B cells are
activated by interaction with T cells and form germinal
centers (GCs) (10, 11). The cellular volume of spleen GC
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Abbreviations used in this paper: 
 
ASC, antibody-secreting cell; CSR, class
switch recombination; CT, cholera toxin; GC, germinal center; i.n., intra-
nasal; MALT, mucosa-associated lymphoid tissue; NALT, nasal-associated
 
lymphoid tissue; NIP, (4-hydroxy-5-indo-3-nitrophenyl)acetyl; NP, 4-hydroxy-
3-nitrophenyl)acetyl; PCLN, posterior cervical LN; PI, propidium iodide;
PNA, peanut agglutinin; RAG, recombination activating gene. 
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peaks at 2 wk after immunization, followed by a reduction
toward the basal level by days 80–100 (12, 13). Concomi-
tantly, long-lived antibody-secreting cells (ASCs) and
memory B cells start to appear 
 
 
 
1–2 wk after immuniza-
tion, and they persist largely without proliferation (14–19).
GCs support a specialized environment for CSR and anti-
gen-driven somatic hypermutation, which randomly diver-
sifies the antibody repertoire (20, 21). The accumulation of
somatic mutations increases the antibody affinity for elicit-
ing antigen, but it might also change the antibody specific-
ity, sometimes resulting in the acquisition of autoreactivity
(22). High affinity B cells selectively receive appropriate
signals through interaction with follicular dendritic cells
and GC Th cells to differentiate into memory B cells (11,
23). Genetic analysis of B cells in human tonsils suggested
that somatic mutation, CSR, and, presumably, selection for
antigen also take place in GCs in MALT (24, 25). To date,
however, it remains largely unknown how the antigen-
specific repertoire is selected and reserved in the mucosal
memory compartment, because of technical difficulties in
the genetic and cellular analysis of the mucosal B cell re-
sponse to defined antigens at the clonal level.
Nasal-associated lymphoid tissue (NALT) is the major
inductive site for the upper respiratory tract and oral cavity
(for reviews, see references 26 and 27), equivalent to
Waldeyer’s ring in humans, consisting of sites such as ade-
noids or tonsils (26). NALT is located in close proximity to
sites of entry by foreign antigens and infectious agents, and
intranasally delivered antigens are taken up from the nasal
cavity preferentially through M cells (26). Thus, NALT is
easily manipulated by intranasal (i.n.) inoculation of anti-
gen (28, 29), providing a useful experimental system for
analyzing antigen-driven selection in GCs and the subse-
quent establishment of a memory compartment in the mu-
cosal immune system.
To investigate antigen-driven selection in NALT GCs
and its role in the establishment of the memory compart-
ment, we took advantage of the genetically highly re-
stricted immune response of C57BL/6 mice to the hapten
(4-hydroxy-3-nitrophenyl)acetyl (NP). In the primary re-
sponse to NP, the majority of the NP-specific B cells ex-
press antibodies encoded by a canonical V
 
H
 
 gene, 
 
V186.2
 
,
paired with 
 
 
 
1 light chain (30, 31). Affinity-driven selec-
tion results in the enrichment of 
 
V186.2
 
 joined to
 
DFL16.1
 
 and 
 
J
 
H
 
2 segments carrying an affinity-enhancing
replacement mutation from tryptophan to leucine at amino
acid position 33 (Trp33 to Leu33), first within the GC B
cell compartment (31–34) and later within the memory
compartment (19, 32, 35). By using these genetic and phe-
notypic markers, we were able to track a very small popu-
lation of NP-specific GC and memory B cells in the mu-
cosal lymphoid tissues.
In this study, we demonstrate that high affinity B cells
were preferentially enriched in the IgA memory compart-
ment in the primary immune response in NALT, despite
the equivalent generation and selection of high affinity B
cells within both the IgG
 
 
 
 and IgA
 
 
 
 GC compartments.
The present data further suggest that high affinity memory
 
B cells not only home back to regional mucosa but also mi-
grate into nonmucosal tissues to establish a long-term
memory compartment predominant in IgA.
 
Materials and Methods
 
Animals and Immunizations.
 
Specific pathogen-free female
C57BL/6 mice and recombination activating gene (RAG)-1
 
 
 
/
 
 
 
mice were purchased from Japan SLC Inc. and The Jackson Lab-
oratory, respectively. Mice 10–12 wk of age were given an i.n.
challenge into each nasal cavity with 3 
 
 
 
l of PBS containing 1 
 
 
 
g
of NP
 
16
 
-CG and 1 
 
 
 
g of cholera toxin (CT; Sigma-Aldrich). As a
control, mice were given an intraperitoneal challenge of 2 
 
 
 
g of
NP
 
16
 
-CG and 2 
 
 
 
g of CT. Some mice received a secondary chal-
lenge of soluble NP
 
16
 
-CG (2 
 
 
 
g i.n. or 20 
 
 
 
g intraperitoneally) 5
or 7 wk after the primary sensitization. All mice were maintained
under specific pathogen-free conditions in accordance with insti-
tutional animal care and use guidelines.
 
Preparation of Nasal and Intestinal Secretions.
 
To collect nasal
secretions, we separated the upper and lower jaws, and the nasal
draining duct to the oral cavity was exposed. The nasal cavity was
flushed with 1 ml of 0.1% BSA in PBS, and the washing was re-
cycled to flush the cavity three times. To collect intestinal secre-
tions, we cut open a piece of small intestine (
 
 
 
6 cm in length)
and rinsed it with 0.1% BSA in PBS with 0.05% sodium azide to
wash out the ingredients. The piece was placed in a fresh dish
containing 2 ml of 0.1% BSA in PBS with 0.05% sodium azide,
and mucosal secretion was scraped from the intestinal lumen with
the plunger of a syringe. The solution containing nasal or intesti-
nal secretions was centrifuged (15,000 rpm) at 4
 
 
 
C for 10 min,
and the supernatant was recovered for analysis.
 
Cell Preparations.
 
NALT localized on the posterior part of the
palate were gently teased out with fine forceps and single cell sus-
pensions prepared by filtering through nylon mesh (28, 29). Pos-
terior cervical LNs (PCLNs) were identified deep within the
musculature of the neck and excised (36). Single-cell suspensions
were prepared from PCLNs and spleens by mechanical disruption
of small fragments of organ between frosted glass slides followed
by filtration through nylon mesh. RBCs were then lysed as de-
scribed previously (34).
 
Cell Transfer.
 
Spleen cells were prepared from C57BL/6
mice as 
 
 
 
4 wk after i.n. immunization with 2 
 
 
 
g of CT adjuvant
and 2 
 
 
 
g of either NP
 
16
 
-CG or CG. Cells were then transferred
into RAG-1
 
 
 
/
 
 
 
 mice on a C57BL/6 background by intravenous
injection (6 
 
 
 
 10
 
7
 
 cells per recipient). 12–24 h after the transfer,
the RAG-1
 
 
 
/
 
 
 
 mice were challenged intraperitoneally with 50
 
 
 
g of soluble NP
 
16
 
-CG. 7 d later, mice were individually bled
and the serum used for ELISA (see below).
 
Flow Cytometry.
 
Single cell suspensions of NALTs, PCLNs,
and spleens were blocked with anti-Fc
 
 
 
RII/III mAb (2.4G2) on
ice for 30 min. GC B cells and memory B cells were identified as
reported previously (12, 19, 37). Briefly, to analyze the kinetics of
IgA
 
 
 
 or IgG2b
 
 
 
 GC and memory cells, we incubated cells with
TexasRed-conjugated anti-CD38 (CD38
 
TX
 
), FITC-labeled anti-
 
 
 
1, and anti-
 
 
 
2 mAbs (anti-
 
 
 
FITC
 
, Ls-136 and 4/1–101), PE-
conjugated (4-hydroxy-5-indo-3-nitrophenyl)acetyl (NIP)-BSA
(NIP-BSA
 
PE
 
), and with biotinylated anti-IgA or anti-IgG2b
mAb, respectively (BD PharMingen). Secondary incubation was
with APC-conjugated streptavidin (streptavidin
 
APC
 
; BD Phar-
Mingen). To analyze NP-specific/
 
 
 
 
 
 GC and memory B cells,
cells were stained with a mixture of biotinylated mAbs against
IgM, IgD, CD43, CD5, and CD90 to exclude naive B cells, anti- 
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body-forming cells (AFCs), B-1 cells, and T cells from the analysis,
as described previously (19). After washing, cells were stained with
anti-CD38
 
TX
 
, APC-conjugated anti-B220 (B220
 
APC
 
), and anti-
 
 
 
FITC
 
 mAbs and with NIP-BSA
 
PE
 
, followed by staining with Tri-
color (TC)-conjugated streptavidin (streptavidin
 
TC
 
; Caltag). The
cells were washed and finally suspended in 5 
 
 
 
g/ml of propidium
iodide (PI) for analysis with a FACSVantage™ (Becton Dickin-
son) as described previously (34). At least 100,000 events were
collected, and the frequency of NIP-binding GC and memory
cells in the viable lymphocyte gate was determined with
CELLQuest™ (version X; Becton Dickinson). To sort GC and
memory B cells in NALTs or PCLNs, we obtained cells from
pooled NALTs (
 
n
 
   
 
80–100) or pooled PCLNs (
 
n
 
   
 
10–30).
Cells were blocked with 2.4G2 and stained with biotinylated
mAbs against IgM, IgD, CD43, CD5, and CD90. After washing,
cells were stained with NIP-BSA
 
PE
 
 and anti-
 
 
 
FITC
 
, anti-CD38
 
TX
 
and anti-B220
 
APC
 
 mAbs, followed by streptavidin
 
TC
 
 and PI as re-
ported previously (19). PI-stained dead cells, IgM
 
 
 
, IgD
 
 
 
,
CD43
 
 
 
, CD5
 
 
 
, and CD90
 
 
 
 cells were excluded by gating and
NIP-binding/B220
 
 
 
/CD38
 
dull
 
/
 
 
 
 
 
 GC B cells and NIP-binding/
B220
 
 
 
/CD38
 
 
 
/
 
 
 
 
 
 memory cells (12, 19, 37) were sorted with a
FACSVantage™ directly into Trizol (GIBCO BRL) containing
50 
 
 
 
g/ml tRNA (Roche Diagnostics). As a control, NIP-bind-
ing/B220
 
 
 
/CD38
 
dull
 
/
 
 
 
 
 
 GC B cells were sorted from spleno-
cytes of C57BL/6 mice (
 
n 
 
  
 
3) immunized intraperitoneally with
2 
 
 
 
g of NP-CG and 2 
 
 
 
g of CT 9 d earlier.
 
ELISA and ELISPOT Assays.
 
ELISA and ELISPOT assays
were performed with NP
 
1
 
-BSA and NP
 
22
 
-BSA as described pre-
viously (35). The frequency of NP-specific AFCs was estimated
among NALT cells, splenocytes, and bone marrow cells, and total
and high affinity NP-specific antibodies were determined in sera.
The quantity of each subclass of NP-specific antibody was
measured with biotinylated goat anti–mouse IgG1 (Biosource
International), IgG2b (Biosource International), IgA (Zymed
Laboratories), or biotinylated anti-
 
 
 
 antibodies (Southern Bio-
technology Associates, Inc.), and with streptavidin-conjugated
horseradish-peroxidase (Roche Molecular Biochemicals) by use
of an isotype-specific standard curve that was constructed in each
assay based on serial dilutions of purified anti-NP 
 
 
 
 
 
 mAb of the
IgG1 and IgG2b subclass (provided by T. Azuma, RIBS, Science
University of Tokyo, Tokyo, Japan). For measurement of NP-
specific IgA antibodies, pooled sera from hyperimmune mice
containing NP-specific IgA antibodies equivalent to 640,000 U
were used as standards, and the quantity was determined as rela-
tive IgA units.
 
Sequence Analysis of VDJ DNA Segments.
 
Total RNA was
prepared from sorted Trizol-solubilized NALT, PCLNs, or
splenic    GC B cells and memory B cells based on the manufac-
turer’s protocol. First-strand cDNA was synthesized with specific
primers, C  5-GTGT/CGCACACC/TG/ACTGGACAGGGA/
CTCCAG/TAG, C  5-CAGCGGCCGCGGCAGCTGGGA,
C  5-GCCAGGCAGCCCATGGCCACC, or with an oligo-dT
primer by use of a Superscript Kit (GIBCO BRL). The C –
specific primer was designed so that all the subclasses of   rear-
rangements ( 1,  2a,  2b, and  3) would be primed. The latter
was confirmed in preliminary experiments with cDNA prepared
from both NP-specific hybridoma clones of each IgG subclass en-
coded by V186.2 gene rearrangements (provided by T. Azuma),
and spleen cells of mice immunized intraperitoneally with alum-
precipitated NP-CG.
2  l of cDNA solution was used as a template in a reaction
volume of 50  l for two rounds of nested PCR for amplifying
the V186.2 gene rearranged to the C  or C  region by use of Pfu
DNA polymerase (Stratagene). The primers used for the nested
PCR were as follows: as a sense-primer, V186.2-specific primers
were used (35); as an antisense primer, C  5-CAGGGGC-
CAGTGGATAGACAGATG, C  5-GTGAATTCAGGCG-
GCCGCTTA, or C  5-AGGGGGCTCTCGCAGGAGACG
was used. PCR products were size-fractionated by agarose gel
electrophoresis and purified with GFX™ PCR DNA and a Gel
Band Purification kit (Amersham Pharmacia Biotech). The puri-
fied fragments were cloned into the PCR-Script™ Amp cloning
vector (Stratagene) according to the manufacturer’s instructions.
The three independent RT-PCR and ligation reactions were
performed and were pooled to create each cDNA library to min-
imize the bias from PCR amplification. At least 20 independent
bacterial Ampr white colonies with insert were sequenced. The
sequence of the VDJ segment in a plasmid vector was determined
with an ABI PRIZM™ Big-Dye Terminator Cycle Sequencing
system (310 Genetic Analyzer; Cetus/Perkin-Elmer). Assignment
of gene usage and somatic mutations was performed with the
BLAST and CLUSTALW programs provided by the DDBJ
(www.ddbj.nig.ac.jp). Redundant sequences were deleted on the
assumption that such clones were derived from a single gene. To
estimate the error mutation-frequency of our RT-PCR cloning
system, germline V186.2 gene rearrangements were amplified
from total RNA of a NP-specific hybridoma, B1–8 (30, 38), and
28 bacterial Ampr colonies were sequenced. The artificial muta-
tion-frequency was estimated to be 1.210 4 base pair (one substi-
tution in 8,232 nucleotides), implying 0.04 mutations per V186.2
gene.
Statistical Analysis. Fisher’s exact test and the Mann-Whitney
nonparametric (two-tailed) test were used with Abacus Concepts,
StatView (Abacus Concepts, Inc.). A P   0.05 was considered to
indicate a significant difference.
Results and Discussion
I.N. Immunization Causes Rapid Expansion of IgA and
IgG2b GC B Cells in NALT. To investigate the dynam-
ics and affinity maturation of IgG  and IgA  B cells in the
primary response to NP in NALT, we immunized C57BL/6
mice intranasally with NP-CG in the presence of CT ad-
juvant and monitored NP-specific B cells in NALT by
flow cytometry with use of the hapten NIP coupled to
BSA as described previously (34). Since preliminary experi-
ments had suggested that IgG2b was the major fraction of
the total IgG response in NALT (data not shown and see
Table I), we monitored NIP-binding IgG2b  cells as rep-
resentative of IgG  B cells.
As shown in Fig. 1 A panel c, intraperitoneal immuniza-
tion with NP-CG and CT induced a rapid expansion of
NIP-binding/CD38dull/B220  and CD38dull/B220dull cells
in the spleen at day 9 after immunization. CD38dull/
B220dull B cells are defined as plasmablasts and AFCs (39)
while CD38dull/B220  cells bound high levels of peanut
agglutinin (PNA) (Fig. 1 A panel e), a feature characteristic
of GC B cells (40). As shown in Fig. 1 A panel d, i.n. inoc-
ulation with NP-CG and CT caused a rapid expansion of
NIP-binding B cells in a B220 /CD38dull population in
NALT at day 7 after immunization,  40-fold above the
level of nonimmunized mice. The majority of NIP-bind-
ing B cells displayed the phenotype of GC B cells (B220 /1600 Selective Affinity Maturation in IgA Memory Response
PNA ), whereas NIP-binding B cells with the phenotype
of plasmablasts and AFCs were much less frequent in
NALT from days 6 to 15 after immunization (Fig. 1 A pan-
els d and f, and data not shown), probably owing to their
migration from NALT into the epithelial layer immediately
after differentiation (references 41 and 42 and see below).
Consistent with this, ELISPOT analysis showed that NIP-
binding/   ASCs were barely detected ( 4 out of 105
mononucleated cells) in NALT from days 7 to 11 after im-
munization (data not shown).
We analyzed the kinetics of NP-specific GC B cells in
NALT (Fig. 1 B and data not shown) by five-color flow
cytometry (references 19 and 34 and see Materials and
Methods). As shown in Fig. 1 B, the frequency of GC B
cells reached a maximum at day 7 and was sustained up to
day 11 after immunization in the immunized mice (n  
80–100 per group) and reduced toward the basal level from
days 13 to 15 after immunization. NIP-binding/   GC B
cells bearing IgG2b and IgA coordinately appeared in
NALT after inoculation with NP-CG and CT; IgG2b 
cells were the major population  3–4 times the number of
IgA  cells, except at day 9 after immunization. In contrast,
intraperitoneal immunization with NP-CG and CT caused
an expansion of NIP-binding IgG1  GC B cells in the
spleen, which dominated over IgG2b  cells (data not
shown and Table I). These results suggest that CSR from
C  to C 2b occurred efficiently in B cells in NALT upon
stimulation with NP-CG and CT.
IgA and IgG GC B Cells Are Equally Mutated and Selected
by Antigens in NALT. Accumulation of somatic muta-
tions within GCs increases antibody affinity for eliciting
antigen, and the subsequent clonal selection allows a selec-
Table I. Summary of   /NIP-binding B Cells with GC (CD38dull) or Memory (CD38 ) Phenotypea
IgG1/2a/2b Y99/DFL16.1 L33/Y99
Day Class %b %b P valuec %b P valuec
SPLGC 9 IgG 90/5/5 21  5.2 (0/19)
NALT 9 IgG 5/10/85 50 0.0823d  5.2 (0/20) 0.0116d
GC IgA 48  0.9999 21.7 (5/23) 0.0511
11 IgG 6/19/75f 88 31.2 (5/16)
IgA 43 0.0332  10.0 (0/11) 0.0598
13 IgG 3/23/74f 45 0.0159d 3.2 (1/31) 0.0134d
IgA 68 0.1098 8.0 (2/25) 0.5806
NALT 11 IgG 0/80/20f 20 0.0034g  10.0 (0/10)
Memory IgA 70 0.0698  10.0 (0/10)  0.9999
13 IgG 8/67/25f 33 0.0177g  8.3 (0/12)
IgA 55 0.4136  9.1 (0/11)  0.9999
PCLNs 11 IgG 20/10/70 30  10.0 (0/10)
GC IgA 62  0.9999  12.5 (0/8)  0.9999
13 IgG 27/9/64 37 27.3 (3/11)
IgA 33  0.9999  16.7 (0/6) 0.5147
15 IgG 9/27/64 27  9.1 (0/11)
IgA 90 0.0075  10.0 (0/10)  0.9999
PCLNs 11 IgG 0/21/79 33  4.2 (0/24)
Memory IgA 71 0.0278  5.9 (0/17)  0.9999
13 IgG 11/18/71 7  3.6 (0/28)
IgA 80  0.0001 45.0 (9/20) 0.0001 0.0015e
15 IgG 16/16/68 35  5.3 (0/19)
IgA 86 0.0261 42.9 (3/7) 0.0135 0.0173e
aThe sequence data are depicted in Fig. 2 except for those of IgG clones of splenic GC at day 9 after immunization. These sequence data are avail-
able from GenBank/EMBL/DDBJ under accession nos. AB057817-AB058198 and AB067398-AB067440.
bThe percentage was calculated as 100  (number of V186.2 clones with each phenotype/number of V186.2 clones). 
cThe Fisher’s P value between the value for IgG and IgA clones at the indicated date after immunization unless noted otherwise.
dThe Fisher’s P value between the value for IgG clones at day 11 and the indicated date after immunization.
eThe Fisher’s P value between the value for IgA clones at day 11 and the indicated date after immunization.
fThe Fisher’s P   0.0138 between the value for IgG2a/IgG2b clones from NALT B cells with GC and memory phenotype at each indicated date af-
ter immunization. 
gThe Fisher’s P value between the value for IgG clones of NALT GC at day 11 and of NALT memory at the indicated date after immunization.1601 Shimoda et al.
tive accumulation of high affinity variants which preferen-
tially differentiate into long-term ASCs and memory cells
(11, 23). To examine whether somatic mutation and anti-
gen-driven selection operate equally well in IgG  and
IgA  GC B cells in NALT in the primary response to NP,
we purified NIP-binding/   GC B cells with a phenotype
of CD38dull/B220 /IgM /IgD /CD43 /CD5 /CD90 
from the pooled NALTs of 80–100 C57BL/6 mice at indi-
cated periods after i.n. inoculation with NP-CG and CT.
As a control, NP-specific GC B cells were purified from
the pooled spleens of C57BL/6 mice immunized intraperi-
toneally with NP-CG and CT 9 d previously.
In C57BL/6 mice, the anti-NP antibody response to T
cell–dependent antigen is dominated by  1  antibodies
whose H-chain variable (V) region is encoded by the V
segment, V186.2 (31, 43, 44). In contrast, the predominant
usage of the rearranged V186.2 gene is barely detected in T
cell–independent responses (45). Thus, first strand cDNA
was synthesized from total RNA of purified cells by use of
either a C ,  C , or C  specific primer or oligo-d(T)
primer, followed by two rounds of nested PCR for prefer-
ential amplification of the VH gene belonging to the
V186.2 or V3 subfamily (35). Subsequently, we sequenced
the amplified VDJ clones to identify the VH gene usage and
any mutations present (Table I and Fig. 2).
We observed that  90% of the VH genes recovered from
NALT GC were encoded by the V186.2 gene segment,
except for the genes isolated at day 11 after immunization
(40% of the recovered VH genes). As summarized in Table
I, among the VDJ-C  clones sequenced, the rearranged
V186.2 genes joined to C 2b (VDJ-C 2b) were dominant
throughout the primary immune response (71–85%). In
contrast, 90% of the total VDJ-C  clones were joined to
C 1 in GC B cells in the spleens of mice immunized intra-
peritoneally with NP-CG and CT at day 9 after immuniza-
tion. Rearranged V186.2 genes joined to C  (VDJ-C )
were not recovered from the spleens of these mice.
As shown in Fig. 2 A and B, NP-specific GC B cells
bearing either IgG or IgA accumulated somatic mutations
in the rearranged V186.2 genes as early as at day 7 after im-
munization. The average number of mutations per rear-
ranged V186.2 gene increased from days 7 to 11 after im-
munization in the VDJ-C  (from 0.9 to 3.7; Fig. 2 A) and
VDJ-C  clones (from 0.8 to 3.1; Fig. 2 B), accompanying
the reduction in the frequency of V186.2 clones with one
or no mutation. These results suggest that both IgG  and
IgA  GC B cells in NALT proliferated and accumulated
somatic mutations at a similar rate in the rearranged
V186.2 genes in the primary immune response. The aver-
age number of mutations per rearranged V186.2 gene,
however, became less frequent from days 11 to 13 after im-
munization (from 3.7 to 1.8 in VDJ-C  and from 3.1 to
2.0 in VDJ-C ) in parallel with the reduction in cell num-
ber. This may reflect preferential egression of the mutated
cells from GC (Fig. 2 A and B).
Antigen-driven clonal selection in C57BL/6 mice in re-
sponse to NP-CG causes the predominant selection of NP-
specific/   antibodies encoded by the V186.2 gene rear-
ranged to DFL16.1 and JH2 segments carrying a tyrosine
residue at position 99 in CDR3 and a replacement muta-
tion from tryptophan (Trp) to leucine (Leu) at position 33
in CDR1 (the Leu33/Tyr99 group). The Leu33 substitu-
Figure 1. Flow cytometric analysis of NP-specific B cells. (A) Spleen cells
were obtained from both nonimmunized C57BL/6 mice (panel a) and mice
immunized intraperitoneally with 2  g of NP-CG and 2  g of CT 9 d ear-
lier (panels c and e). Pooled NALT cells (n   20–25 mice) were also ob-
tained from nonimmunized C57BL/6 mice (panel b) as well as from mice
immunized i.n. with 2  g of NP-CG and 2  g of CT 7 d earlier (panels d
and f). Cells were stained with anti-B220TX and anti-CD38APC mAbs and
with NIP-BSAPE, PNAFITC, and PI. Viable cells (PI ) were selected under a
lymphocyte gate based on forward and side light scatter. Thereafter, the
NIP-binding cells were gated, and the expression of B220 and CD38 was
analyzed (panels c and d). Finally, the CD38dull population was gated, and
binding to PNA was analyzed among the NIP-binding cells (panels e and f).
Figures in each region represent the number of CD38dull/NIP-binding/
B220  or B220dull cells (panels a–d) and that of CD38dull/NIP-binding/
B220 /PNA  or CD38dull/NIP-binding/B220dull/PNA  cells (panels e and
f) per 100,000 total viable cells. (B–D) Cells were prepared from pooled
NALT (B, n   20–25 mice) and PCLNs (C and D, n   5–20) at various
times after i.n. immunization (as above) as well as from nonimmunized
mice. To monitor NP-specific/   GC and memory B cells, cells were first
stained with biotinylated mAbs against IgM, IgD, CD43, CD5, and CD90.
This was followed by staining with NIP-BSAPE and anti-CD38TX,
anti- FITC, and anti-B220APC mAbs. After washing, cells were stained
with streptavidinTC and PI to exclude from the analysis dead cells and
the cells recognized by the biotinylated mAbs. To track NP-specific/  
IgA  or IgG2b  GC and memory B cells, cells were stained with anti-
CD38TX mAb, anti- FITC mAb, NIP-BSAPE, and with biotinylated
anti-IgA or IgG2b mAb, followed by incubation with APC-conjugated
streptavidin and PI. Viable cells were selected under a lymphocyte gate
based on forward and side light scatter. Shown are the frequencies of NIP-
binding/   GC B cells ( ) and NIP-binding/   IgG2b  ( ) or IgA  ( )
GC B cells in NALT (B) and PCLNs (C). Also shown are the frequencies
of NIP-binding/   memory B cells ( ) and NIP-binding/   IgG2b  ( )
or IgA  ( ) memory B cells in PCLN (D). Each symbol represents the re-
sult from a single experiment. Frequency was estimated by dividing the
number of cells with each phenotype by the total number of viable cells. At
least 105 events were collected for each frequency determination.1602 Selective Affinity Maturation in IgA Memory Response
tion usually yield  10-fold increase in affinity for NP in
antibodies from primary and secondary NP-specific ASCs
(31, 44, 46) and NP-specific GC B cells (unpublished data).
In this context, as shown in Fig. 2 and Table I, the Leu33/
Tyr99 group was transiently selected in 22% of the VDJ-
C  clones from NALT GC B cells at day 9 after immuni-
zation (P   0.0511), but this selection was not apparent in
the VDJ-C  clones at that period. From days 9 to 11 after
immunization, the VDJ-C  clones increased the R/S ratio
in CDR1 and CDR2 above the value expected in random
mutations (P   0.0109, data not shown) and enriched the
Leu33/Tyr99 group (31%, P     0.0116); however, the
Leu33/Tyr99 group became less frequent from days 11 to
13 after immunization (P   0.0134). These results suggest
that the VDJ-C  clones were highly selected by antigen at
day 11 after immunization, but the selection was transient.
It has been suggested that antigen-driven clonal selection
at a later stage of the primary response results in the enrich-
ment of high affinity anti-NP antibodies encoded by
VH186.2-D-J gene segments with glycine at position 99 in
CDR3 (the Tyr33/Gly99 group), in association with a
number of somatic mutations except for the Leu33 replace-
ment (19, 44). The Tyr33/Gly99 group appeared in the
VDJ-C  and VDJ-C  clones in NALT GC at a low fre-
quency, accompanied by a small number of mutations (Fig.
2 A and B), compatible with the view that these clones are
not selected in NALT B cells during the early primary re-
sponse, as expected (19, 44).
Taken together, these results support the notion that in-
troduction of somatic mutations and subsequent antigen-
driven selection operates equally well in both NP-specific
IgA  and IgG  GC B cells in NALT after i.n. inoculation
with NP-CG and CT.
Memory B Cells Are Barely Detected in NALTs after Immu-
nization but Appear in the Draining LNs, PCLNs. We have
previously observed that NP-specific IgG1  memory cells
were enriched in IgM /IgD /CD38  B cells in the spleen
of C57BL/6 mice after intraperitoneal immunization with
NP-CG in alum (19). Memory B cells appeared behind
the peak response of GC and reached a plateau at a fre-
quency of 1–2   10 4 per mononucleated spleen cell, 10–
20 times below the peak level of GC B cells (12, 19). In
NALT, however, we observed that the frequency of
IgG2b  and IgA  B cells with a memory phenotype was
low,  100 times below the level of GC B cells ( 10 5 per
mononucleated cell; data not shown). NALT are consti-
tuted bilaterally of two separate organs (26–28) that con-
tain 2–4   105 mononucleated cells in immunized
C57BL/6 mice (data not shown), implying that NALT
could retain only 2–4 memory cells during the immune
response, if any. Nevertheless, to examine B cell selection
in the memory compartment, NIP-binding/   B cells
with a memory phenotype (B220 /CD38 /IgM /IgD /
CD43 /CD5 /CD90 ) were purified from pooled
NALTs (n   85–100) at days 11 and 13 after immuniza-
tion and subjected to PCR that amplifies VDJ-C  and
VDJ-C  clones. The sequence analysis revealed that, un-
like the VDJ-C  clones of NALT GC B cells, clones from
Figure 2. Accumulation of somatic mutations and affinity maturation
in NP-specific GC B cells (A, B, E, F) and memory B cells (C, D, G, H)
in NALTs (A–D) and PCLNs (E–H) of C57BL/6 mice after i.n. immuni-
zation with NP-CG and adjuvant CT. NIP-binding/   GC B cells
(CD38dull/B220 /IgM /IgD /CD43 /CD5 /CD90 ) and NIP bind-
ing/   memory B cells (CD38 /B220 /IgM /IgD /CD43 / CD5 /
CD90 ) were purified from the pooled NALTs (n   80–100) or PCLNs
(n   10–30) of NP-CG primed C57BL/6 mice at various times after im-
munization. Messenger RNA was purified from sorted cells, and cDNA
synthesized by reverse transcriptase with specific primers for either C  (A,
C, E, G) or C  (B, D, F, H). Thereafter, the rearranged VH genes were
amplified from the cDNA by PCR. The frequency of artificial substitu-
tions was calculated to be 1.210 4 base pair in control experiments using
messenger RNA from the hybridoma B1–8 (see Materials and Methods).
VH genes encoded by V186.2 were dominant among the recovered
clones and were selected for further analysis (see Table I). Shown are the
numbers of somatic mutations in individual V186.2 genes with ( ) or
without ( ) a Trp-to-Leu substitution at position 33 (Leu33) and genes
with Gly at amino acid 99 in CDR3 ( ) recovered at the indicated date.
The average number of somatic mutations of V186.2 genes (white col-
umns) at the indicated date was determined by dividing the total number
of somatic mutations observed by the number of clones. The sequence
data are available from GenBank/EMBL/DDBJ under accession nos.
AB057817-AB058198 and AB067398-AB067440.1603 Shimoda et al.
memory B cells taken at days 11 and 13 after immunization
were dominated by the V186.2 gene segment with one or
no mutation joined to C 2  (Fig. 2 C and Table I). Like-
wise, as shown in Fig. 2 D, eight out of ten VDJ-C 
clones sequenced had a low number of mutations at day 11
after immunization and the average number of mutations
per VDJ-C  gene reduced from 2.4 to 0.7 at day 13 im-
munization. Furthermore, in contrast to NALT GC B
cells, the Leu33/Tyr99 group was barely detected in both
VDJ-C  and VDJ-C  clones of NALT memory B cells
(see Table I and Fig. 2 C and D). Thus, the low frequency
of memory B cells together with the difference in genetics
between NALT GC and memory B cells suggest that high
affinity B cells generated in NALT GC could not be re-
tained in NALT as a memory population.
We observed that the primary and secondary i.n. chal-
lenge with NP-CG caused secretion of a large amount of
high affinity anti-NP IgA antibodies in nasal wash (data not
shown). This led us to speculate that the newly differenti-
ated memory B cells in NALT could promptly emigrate
from the tissue and home back to reside underneath the ep-
ithelial cell layer of NALT, as observed previously in hu-
man NALT (41).
Since NALT preferentially drain to PCLNs (26, 27), we
speculated that memory B cells generated in NALT could
emigrate into the draining PCLNs through the lymphatic
system and then to thoratic duct that joins the systemic cir-
culation (42). As shown in Fig. 1 C, NIP binding/   GC
B cells appeared in the PCLNs at day 9 and reached a pla-
teau at days 11 to 15 after immunization, 4 d behind the
response in NALT. This is in agreement with the view that
NALT is the primary inductive site upon i.n. immuniza-
tion (26–29). The frequency of GC B cells in PCLNs was
 1–2   10 4 PCLN cells, 10 times below the level ob-
served in NALT. The frequency of NIP-binding/  /
IgG2b  GC B cells that were the dominant subclass of IgG
in the response was five times more than IgA  GC B cells
throughout the reaction.
Fig. 1 D shows that NIP-binding B cells with memory
phenotype transiently appeared in PCLNs, and peaked at
day 11 after immunization at a frequency comparable to
that of GC B cells. We observed that PCLNs consist of
2–5   106 cells in immunized mice,  10 times higher than
NALT. Therefore, assuming that PCLN GC produce
memory B cells at a similar rate to that observed for splenic
GCs (see above and references 12 and 19), memory B cells
derived from PCLN GC would amount to 100 cells per
mouse at most. This would represent  20% of the esti-
mated number of PCLN memory B cells (based on the
FACS® data in Fig. 1 D). Notably, the frequency of IgA 
memory B cells was comparable with that of IgG  memory
B cells throughout the immune response (Fig. 1 D), and
the frequency was 10 times higher than the expected value
based on the frequency of IgA  PCLN GC B cells. There-
fore, taking into account the low frequency of NALT
memory B cells throughout the response, it is conceivable
that IgA  memory B cells generated in NALT emigrate
into the draining PCLNs (also see below).
High Affinity B Cells Are Enriched Exclusively in the IgA
Memory Compartment in PCLNs. We purified NIP-bind-
ing/  /B220 /CD38dull GC and NIP-binding/  /
B220 /CD38  memory B cells from pooled PCLNs (n  
20–30) by FACS® (see Materials and Methods) and con-
ducted PCR to amplify VDJ-C  and VDJ-C  clones. As
shown in Table I and Fig. 2 E, the VDJ-C  clones isolated
from PCLN GC B cells transiently accumulated the Leu33
replacement and had increased numbers of mutations by
day 15 after immunization. To our surprise, the VDJ-C 
clones isolated from B cells with memory phenotype in
PCLNs did not carry the Leu33 replacement, nor did they
have an increased average number of mutations from days
11 to 21 after immunization (Fig. 2 G). Thus, it appears
that IgG  B cells selected by antigen in GC reactions of
PCLNs (Fig. 2 E) and NALT (Fig. 2 A) were largely miss-
ing from the IgG memory compartment of PCLNs.
Unlike the VDJ-C  clones, the VDJ-C  clones isolated
from PCLN GC B cells neither increased in average num-
ber of mutations nor accumulated the Leu33 replacement
from days 11 to 15 after immunization (Fig. 2 F and Table
I). However, the VDJ-C  clones of memory B cells in
PCLNs increased the average number of somatic muta-
tions, accompanying accumulation of the affinity-enhanc-
ing Leu33 replacement at high frequency at days 13 and 15
after immunization (P   0.0015 and P   0.0173, respec-
tively; Fig. 2 H and Table I). Like the VDJ-C  clones iso-
lated from NALT GC B cells at day 11 after immunization,
the VDJ-C  clones of memory B cells in PCLNs at days 13
and 15 after immunization consisted largely of the V186.2
genes joined to DFL16.1 and JH2 that carries Tyr99
( 80%, Table I), significantly different from the VDJ-C 
clones of memory B cells in PCLNs (P   0.0261, Table I).
These results suggest that high affinity B cells are preferen-
tially enriched in the IgA  memory compartment with
time after i.n. immunization with NP-CG. In contrast, the
NP-specific IgG  memory compartment is hardly occu-
pied by high affinity B cells, despite the fact that CSR and
antigen-driven selection were operated equally well in
both the IgG  and IgA  GC compartments.
I.N. Immunization Followed by Intraperitoneal Challenge
Causes Systemic Immune Response with High Affinity IgA.
In agreement with the selective development of high-affin-
ity IgA memory B cells in PCLNs described previously, we
observed remarkable IgA affinity maturation in nasal secre-
tions after primary and secondary i.n. inoculation with NP-
CG and CT (data not shown). However, we could not an-
alyze affinity maturation in anti-NP IgG antibodies because
these antibodies were barely detected in nasal secretions
(data not shown).
Therefore, to examine affinity maturation in the second-
ary response, we challenged C57BL/6 mice intraperito-
neally with 20  g of NP-CG, 5 wk after i.n. inoculation
with NP-CG and CT. 7 d after the secondary challenge,
the number of NP-binding/ 1
  ASCs in the spleen and
bone marrow and the amount of anti-NP antibodies in the
sera were determined by ELISPOT and ELISA, respec-
tively. As shown in Fig. 3 A, the secondary intraperitoneal1604 Selective Affinity Maturation in IgA Memory Response
challenge caused a substantial increase in the number of
NP-binding/ 1
 /IgA  ASCs in the spleen and bone mar-
row. NP-binding/ 1
 /IgG2b  ASCs were also increased
in the spleen of mice primed i.n. with NP-CG and CT,
but not in control mice primed with CG and CT.  90%
of NP-binding/ 1
 /IgA  ASCs secreted high affinity anti-
bodies, whereas NP-binding/ 1
 /IgG2b  ASCs did not.
In agreement with the ELISPOT results, the secondary
challenge with NP-CG resulted in increased levels of anti-
NP IgA and IgG2b antibodies in the sera of mice primed
i.n. with NP-CG and CT,  100 and 10 times above the
level of mice primed with CG and CT, respectively (Fig. 3
B). Again, IgA antibodies were comprised largely of high
affinity antibodies ( 90%), whereas the proportion of high
affinity antibodies was less in IgG2b (46% on the average;
Fig. 3 C, P   0.0286). A significant difference in the affin-
ity maturation between IgA and IgG2b serum antibodies
was reproducible (data not shown).
As shown in Fig. 3 A and B, the secondary challenge
with NP-CG did not cause any significant secondary re-
sponse with IgG1 ASCs and IgG1 antibodies (Fig. 3 C,
P   0.0286) in the mice primed i.n. with NP-CG and CT,
suggesting that the primary i.n. inoculation with NP-CG
and CT does not efficiently develop IgG1 memory B cells
(see Table I).
Migration of Memory B Cells into Nonmucosal Lymphoid
Tissues via the Systemic Circulation. To examine whether
high affinity IgA memory B cells migrate into nonmucosal
tissues through the systemic circulation as predicted above,
we obtained splenocytes from the pooled spleens (n   5–6)
of C57BL/6 mice that had been primed i.n. with CT and
either NP-CG or CG 7 wk previously. These cells were
transferred into RAG-1 /  mice on a C57BL/6 back-
ground, followed by challenge with soluble NP-CG. 10 d
later, we estimated anti-NP antibody levels in serum by
ELISA. As shown in Fig. 4 A, the RAG-1 /  mice recon-
stituted with NP-CG–primed splenocytes produced a sig-
nificant amount of anti-NP antibodies of the IgA subclass
after immunization with NP-CG,  10-fold above the
level of RAG-1 /  mice reconstituted with CG-primed
cells. In contrast, the level of anti-NP IgG1  and IgG2b 
antibodies in RAG-1 /  mice reconstituted with NP-CG–
primed splenocytes was less than twofold above the level of
mice reconstituted with CG-primed cells. In addition, anti-
NP IgA antibody was dominated by high affinity antibodies
(70%), whereas high affinity antibodies were less frequent
among IgG1  and IgG2b  antibodies compared with the
level of IgA antibodies (P   0.0571 and P   0.0286, re-
spectively; Fig. 4 B).
Taken together, these results demonstrate that B cell ac-
tivation in NALT upon stimulation with NP-CG and CT
resulted in a clonal dominance of high affinity B cells in the
IgA  memory compartment, although antigen-driven se-
Figure 3. Dominance of high affinity IgA in the secondary response af-
ter i.n. immunization. C57BL/6 mice were primed i.n. with 2  g of NP-CG
and CT, followed by intraperitoneal challenge with 20  g of either NP-CG
(a) or CG (c) 5 wk later. As a control, mice were i.n. immunized with 2
 g of CG plus CT, followed by intraperitoneal challenge with NP-CG
(b). 7 d after the intraperitoneal challenge, immune serum, spleen, and
bone marrow were obtained from individual mice (n   4). All data are
representative of three independent experiments. (A) The numbers of to-
tal ( ) and high affinity ( ) NP-binding/ 1
  ASCs with IgA, IgG2b, and
IgG1 subclasses were determined by ELISPOT. Columns represent the
average number of total (white columns) and high affinity ASCs (black
columns). (B) Total ( ) and high affinity ( ) NP-specific antibody titers
of IgA, IgG2b, and IgG1 subclass in serum from individual mice (n   4)
were determined by ELISA. (C) Isotype-specific serum antibody affinity
maturation was estimated for the individual mice (n   4) shown in group
a of B by dividing the high affinity NP-specific antibody titer by the total
NP-specific antibody titer. Serum affinity maturation of NP-specific anti-
bodies between IgA and IgG2b or IgG1 was statistically evaluated by the
Mann-Whitney nonparametric tests (two-tailed).
Figure 4. High affinity IgA memory cells generated in
NALT migrate into nonmucosal lymphoid tissues such as
spleen. C57BL/6 were immunized i.n. with 2  g of CT
and 2  g of either NP-CG (a) or CG (b). 4 wk later, single
cell suspensions were prepared from pooled spleens (n   4)
and transferred into RAG-1 /  mice on a C57BL/6 back-
ground by intravenous injection (6   107 cells per recipi-
ent). 12–24 h after the transfer, the reconstituted RAG-1 / 
mice were immunized intraperitoneal with 50  g of
NP-CG. All data are representative of three independent
experiments. (A) 7 d later, the levels of NP-specific anti-
bodies ( ) and high affinity NP-specific antibodies ( ) of IgA, IgG2b, and IgG1 subclasses in individual sera (n   4) were determined by ELISA. White
and black columns represent the mean titer of total and high affinity anti-NP antibodies, respectively. (B) Isotype-specific serum antibody affinity matu-
ration was estimated for the individual mice (n   4) shown in group (a) of A by dividing the high affinity NP-specific antibody titer by the total NP-spe-
cific antibody titer. Serum affinity maturation of NP-specific antibodies between IgA and IgG2b or IgG1 was statistically evaluated by the Mann-Whit-
ney nonparametric tests (two-tailed).1605 Shimoda et al.
lection appeared to operate equally well in the IgG  and
IgA  GC compartments in NALT.
IgA  memory B cells were barely detected in NALT but
transiently appeared in PCLNs at a level similar to that of
IgA  GC B cells, 4 d behind the peak of GC response in
NALT. The rearranged V186.2 genes from IgA  memory
B cells in PCLN exhibited indications of antigen-driven se-
lection comparable in several respects to the features of
V186.2 genes in the IgA  GC B cells in NALT. However,
IgA  GC B cells in PCLNs had a low number of mutations
throughout the immune response, with no association with
the affinity-enhancing Leu33 mutation (Table I and Fig. 2
F). The differences in VDJ-C  clonotypes between GC B
cells and memory B cells in PCLNs support the view that
IgA  memory B cells in PCLNs represent the progeny of
IgA  GC B cells generated in NALT but not in PCLNs.
Although NP-specific IgG2b  GC B cells dominated
over the IgA  GC B cells in NALT and PCLNs after im-
munization, the number of IgG2b  and IgA  memory B
cells was almost comparable throughout the immune re-
sponse in PCLNs. IgG2b  GC B cells accumulated muta-
tions with indications of affinity maturation during the
peak response in NALT and PCLNs, while such features
were hardly observed in IgG2b  memory B cells in
PCLNs. The correlation of high affinity IgA dominance
with a lack of high affinity IgG in PCLN memory B cells
(Table I and Fig. 2 G and H) led us to speculate that prefer-
ential enrichment of high affinity IgA  memory cells might
be a result of enhanced CSR at C  during sequential CSR
from C  to C  via C  in high affinity IgG  GC B cells in
NALT and PCLNs.
Sequential CSR from C  to C  via C  was detected in
the development of IgA-producing cells in vitro in the
presence of TGF-  (7, 47), in which sequential CSR from
C  to C  via C 2b appeared to be dominant (7). In addi-
tion, in mutant mice depleted of IgA, TGF- , and TGF- 
receptor type II, the deficiency in the development of IgA-
expressing plasma cells is associated with enhancement of
IgG expression in serum, mucosal secretions, and Peyer’s
patches (9, 48, 49), compatible with the notion that se-
quential CSR could be frequent in vivo. B cell function
mediated by B cell receptor depends on antibody avidity,
which is associated with the number and affinity of surface
Igs (50, 51). High affinity B cells may gain more potent
APC function (50, 51), which may, in turn, result in fre-
quent contact with Th cells. Several in vitro studies have
emphasized the significance of CD40 signaling in IgA CSR
(8, 47, 52). Therefore, cognate interaction between Th
cells not only through B cell receptor but, together with
coreceptors, may deliver the signal(s) for chromosomal ac-
cessibility at the Ig locus that are essential for sequential
CSR from C  to C  in the mucosal environment. How-
ever, we could not exclude the possibility at present that
the differentiation of high affinity IgG GC B cells into
ASCs and memory cells is impaired in NALT. Further
analysis is needed to clarify this issue.
This study demonstrates that a GC reaction is rapidly in-
duced in NALT after i.n. inoculation with a minute
amount of NP-CG and CT. However, it remains un-
known whether mucosal GCs in NALT are structurally
and functionally compatible with GCs formed in the spleen
and peripheral LNs. We observed that NP-specific B cells
indicative of affinity maturation were selected among IgA 
B cells earlier than among IgG  B cells in NALT GC after
immunization (Fig. 2 A and B). In taking account of possi-
ble isotype-specific signaling events (53), it is worthwhile
to analyze whether the structural differences in the trans-
membrane and cytoplasmic domains of IgA and IgG might
be responsible for the isotype-dependent selection in
NALT GC.
GC B cells in the spleen continuously accumulate so-
matic mutations over long periods after intraperitoneal im-
munization with NP-CG in alum (19), whereas NALT
GC B cells appeared to undergo transient accumulation of
mutations. Likewise, IgA  GC B cells with indications of
affinity maturation increased in number in NALT at day 9
after immunization, whereas these cells became undetect-
able from days 9 to 11 after immunization (Fig. 2 A and
Table I). Interestingly, however, IgA  GC B cells with in-
dications of affinity maturation reappeared later at day 13
after immunization (Fig. 2 A and Table I). It would be
worthwhile to analyze whether or not the reappearance
reflects sequential CSR from C  to C  via C  in high af-
finity IgG B cells. The transient nature of enrichment of
high affinity variants in GC may imply that the high affin-
ity GC B cells immediately differentiated into long-term
ASCs and/or memory cells and quickly left GC. Consis-
tent with this possibility, we observed that high affinity
IgA antibodies started to appear in nasal secretions at day
11 after primary immunization and accounted for 40% of
total anti-NP IgA antibodies at day 21 immunization (data
not shown).
Previous reports suggest that memory B cells reach a pla-
teau after the peak response of GC and retain this level for
long periods in the spleen after intraperitoneal immuniza-
tion with NP-CG (12, 19). However, it appears that mem-
ory B cells differentiated from NALT GC B cells promptly
migrate into the draining LNs through the lymphatic sys-
tem and then further migrate into the general circulation,
rather than being retained in these lymphoid tissues for a
longer period. A fraction of these memory B cells at least
may reside in the spleen and nasal mucosa. The less effi-
cient retention of memory B cells in NALTs and PCLNs
may in part be related to their histological organization, be-
ing distinct from the spleen where memory B cells often
localize in the marginal zone (10, 54).
In summary, this study sheds light on the GC reaction
responsible for generating mucosal memory B cells. Our
genetic analysis suggests that NALTs preferentially select
high affinity IgA  B cells in the memory compartment.
This mechanism has the great advantage of facilitating im-
munity with noninflammatory, high affinity secretory IgA
antibodies with far greater efficiency than that of other sub-
classes of antibodies. Whether this system is unique to
NALTs or common to other mucosal lymphoid tissues re-
mains to be elucidated.1606 Selective Affinity Maturation in IgA Memory Response
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